Cystathionine Beta Synthase as a Risk Factor for Alzheimer Disease
Journal:
Current Alzheimer Research
Volume:
1
Page:
127-133
Author(s):
Katrin Beyer, Jose I. Lao, Cristina Carrato, Ana Rodriguez-Vila, Pilar Latorre, Maria Mataro, Maria A. Llopis, Jose L. Mate and Aurelio Ariza
Gene Therapy Approaches for the Prevention of Restenosis
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
183-189
Author(s):
Christoph W. Kopp and Rainer de Martin
Pharmacotherapy for Intermittent Claudication: From Consensus-Based to Evidence-Based Treatment
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
1-15
Author(s):
Roberto Antonio Mangiafico and Carmelo Erio Fiore
Moderate Hyperhomocysteinemia and Immune Activation
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
107-118
Author(s):
K. Schroecksnadel, B. Frick, B. Wirleitner, C. Winkler, H. Schennach and D. Fuchs
Cilostazol as a Unique Antithrombotic Agent
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2289-2302
Author(s):
Junichi Kambayashi, Yongge Liu, Bing Sun, Yasmin Shakur, Masuhiro Yoshitake and Frank Czerwiec
Treatment of Chronic Peripheral Arterial Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
205-216
Author(s):
P. L. Antignani
A Novel Therapeutic Strategy Against Vascular Disorders with Chymase Inhibitor
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
217-224
Author(s):
Shinji Takai and Mizuo Miyazaki
Genetic Variations of the Hemostatic System as Risk Factors for Venous and Arterial Thrombotic Disease
Journal:
Current Genomics
Volume:
4
Page:
309-336
Author(s):
R. F. Franco, M. D. Trip and P. H. Reitsma
Matrix Metalloproteinases: A Therapeutic Target in Cardiovascular Disease
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1033-1040
Author(s):
M. J. Sierevogel, G. Pasterkamp, D. P.V. de Kleijn and B. H Strauss